On February 18, 2020 Heska Corporation (NASDAQ: HSKA – News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, reported that Kevin Wilson, Heska’s President & Chief Executive Officer, will present at the Raymond James 41st Annual Institutional Investors Conference on Tuesday, March 3, 2020 at 9:50 a.m. ET in Orlando, FL (Press release, Heska, FEB 18, 2020, View Source [SID1234554471]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Wilson will also be available for one-on-one meetings on March 3rd. To schedule a meeting, please contact Raymond James at [email protected] or Heska Investor Relations at [email protected].

A live webcast of the company’s presentation can be accessed at View Source

The webcast will be archived shortly after the event, and a replay will be available on the company’s website for 90 days following the conference. A copy of the presentation will be available on Heska’s website at View Source